Search - tctmd.com

Displaying 141 - 160 of 182

Sort: Relevancy | Date

News Daily News

El Antídoto de Rivaroxaban parece Seguro y Eficaz en un Estudio Preliminar

December 30, 2013

Presentation

Comparison of the Efficacy and Safety of New Oral Anticoagulants with Warfarin in A-fib Patients

Presenter: C.T. Ruff

December 15, 2013

Presentation

New Oral Anticoagulants and the Risk of Intracranial Hemorrhage

Presenter: Saurav Chatterjee

December 15, 2013

Presentation TCT 2013

Management of a Patient on Novel Oral Anticoagulants Needing Urgent Cath

Presenter: Michael Ezekowitz

October 31, 2013

Presentation TCT 2013

Pulmonary Embolism: When to Use Lytics, When to Use Novel Oral Anticoagulants

Presenter: Ori Ben-Yehuda

October 31, 2013

Presentation TCT 2013

Novel Oral Anticoagulants for Atrial Fibrillation: What You Need to Know to Use Them Safely

Presenter: Jonathan Halperin

October 31, 2013

Presentation TCT 2013

Who Should Receive the New Chronic Oral Anticoagulants? Which One?

Presenter: Christopher Granger

October 27, 2013

News Conference News ESC 2013

New Alternatives Match Efficacy to Warfarin in High-Risk Subgroups

Caitlin E. Cox

September 03, 2013

News Conference News ESC 2013

Novel Anticoagulant Edoxaban Surpasses Warfarin Across Spectrum of VTE Patients

Caitlin E. Cox

September 02, 2013

News Daily News

El Riesgo Hemorrágico de la Terapia Triple No lo Atenúa la Warfarina Bien Controlada

August 30, 2013

News Daily News

Bleeding Risk of Triple Therapy Not Attenuated by Well-Controlled Warfarin

August 30, 2013

News Daily News

Nonvalvular A-fib Patients More Likely to Remain on Dabigatran Than Warfarin

Jason Kahn

August 12, 2013

News Daily News

Apixaban Noninferior to Standard Therapy for Acute Venous Thromboembolism

L.A. McKeown

July 05, 2013

News Daily News

Oral Anticoagulant Use for A-fib in Community Practice Appears Appropriate

June 21, 2013

News Daily News

El Uso de Anticoagulantes Orales contra la FA en Prácticas de la Comunidad parece Apropiado

June 21, 2013

News Daily News

LAA Occlusion More Cost-effective Than Both Warfarin and Dabigatran for A-fib Patients

Yael L. Maxwell

June 07, 2013

News Daily News

La ESC Ofrece Recomendaciones para el Uso de Nuevos Anticoagulantes Orales

Yael L. Maxwell

May 03, 2013

News Daily News

ESC Offers Recommendations on Use of New Oral Anticoagulants

Yael L. Maxwell

May 03, 2013

Presentation Fellows 2013

Navigating the New Chronic Oral Anticoagulants and How to Deal with Triple Therapy

Presenter: Manesh Patel

April 16, 2013

News Daily News

Yet Another Novel Anticoagulant Shows Promise for Preventing Stroke in A-fib

March 28, 2013

Advertisement

El Antídoto de Rivaroxaban parece Seguro y Eficaz en un Estudio Preliminar

Comparison of the Efficacy and Safety of New Oral Anticoagulants with Warfarin in A-fib Patients

New Oral Anticoagulants and the Risk of Intracranial Hemorrhage

Management of a Patient on Novel Oral Anticoagulants Needing Urgent Cath

Pulmonary Embolism: When to Use Lytics, When to Use Novel Oral Anticoagulants

Novel Oral Anticoagulants for Atrial Fibrillation: What You Need to Know to Use Them Safely

Who Should Receive the New Chronic Oral Anticoagulants? Which One?

New Alternatives Match Efficacy to Warfarin in High-Risk Subgroups

Novel Anticoagulant Edoxaban Surpasses Warfarin Across Spectrum of VTE Patients

El Riesgo Hemorrágico de la Terapia Triple No lo Atenúa la Warfarina Bien Controlada

Bleeding Risk of Triple Therapy Not Attenuated by Well-Controlled Warfarin

Nonvalvular A-fib Patients More Likely to Remain on Dabigatran Than Warfarin

Apixaban Noninferior to Standard Therapy for Acute Venous Thromboembolism

Oral Anticoagulant Use for A-fib in Community Practice Appears Appropriate

El Uso de Anticoagulantes Orales contra la FA en Prácticas de la Comunidad parece Apropiado

LAA Occlusion More Cost-effective Than Both Warfarin and Dabigatran for A-fib Patients

La ESC Ofrece Recomendaciones para el Uso de Nuevos Anticoagulantes Orales

ESC Offers Recommendations on Use of New Oral Anticoagulants

Navigating the New Chronic Oral Anticoagulants and How to Deal with Triple Therapy

Yet Another Novel Anticoagulant Shows Promise for Preventing Stroke in A-fib

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content